P

Inventor

XU HONGJIANG

CN32 patents
⚠️ This page may combine multiple inventors who share the name “XU HONGJIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD

26 patents
US10251876B2Apr 9, 2019

Method for treating tumour, pharmaceutical composition and medicinal kit

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD7 citations82
US11597716B2Mar 7, 2023

N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD5 citations72
US10745383B2Aug 18, 2020

1,3,5-triazine derivative and method of using same

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2 citations72
US12319689B2Jun 3, 2025

Methyl- and trifluoromethyl-containing disubstituted sulfonamide selective BCL-2 inhibitor

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2 citations70
US10231973B2Mar 19, 2019

Salts of quinazoline derivative and method for preparing the same

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD1 citations61
US12240811B2Mar 4, 2025

N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition and uses thereof

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations60
US12195468B2Jan 14, 2025

TLR7 agonist for treating colorectal cancer and pharmaceutical combination thereof

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations60
US12128047B2Oct 29, 2024

TLR7 agonist and pharmaceutical combination thereof for treating lung cancer

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations60
US12116356B2Oct 15, 2024

N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations60
US10570141B2Feb 25, 2020

Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereof

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD1 citations60
US12508258B2Dec 30, 2025

Quinoline derivative for treating rheumatoid arthritis

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations59
US11773079B2Oct 3, 2023

Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations56
US11021464B2Jun 1, 2021

Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine methanesulfonic acid salt

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations56
US10035792B2Jul 31, 2018

Resorcinol derivative as HSP90 inhibitor

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD1 citations52
US12336996B2Jun 24, 2025

Drug combination containing TLR7 agonist

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations50
US11572372B2Feb 7, 2023

Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations50
US10858340B2Dec 8, 2020

Crystal of salt of quinazoline derivative

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations50
US10329277B2Jun 25, 2019

N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-OXO-2,3-dihydro-1h-benzo[d]imidazol-1-yl)pyrimidin-2-yl)amino)phenyl)acrylamide hydrochloride as an inhibitor of epidermal growth factor receptor activity

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations50
US12371431B2Jul 29, 2025

Trifluoromethyl-substituted sulfonamide as BCL-2-selective inhibitor

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations48
US11534398B2Dec 27, 2022

Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use in preparing drugs for treating respiratory system diseases

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations48
US11396503B2Jul 26, 2022

Sulfonyl substituted bicyclic compound which acts as ROR inhibitor

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations48
US12030880B2Jul 9, 2024

Iminosulfanone compound as bromodomain protein inhibitor and pharmaceutical composition and medical use thereof

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations47
US11466024B2Oct 11, 2022

Bicylic compound acting as an inhibitor

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations47
US11891405B2Feb 6, 2024

Furo[3,4-b]pyrrole-containing BTK inhibitor

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations45
US10829492B2Nov 10, 2020

Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations39
US10766912B2Sep 8, 2020

Silicon-containing compound for resistance to hepatitis C virus infection

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations34

BIOSION INC

2 patents

CRRC TANGSHAN CO LTD

2 patents

HU WENHUI

1 patent

YUAN ZHEDONG

1 patent